Perceived adverse consequences associated with MDMA/Ecstasy use among young polydrug users in Ohio: Implications for intervention

International Journal of Drug Policy

Volumn 15, Issue 4, 2004, Pages 265-274

  Carlson, Robert G ^a   McCaughan, Jill A ^a   Falck, Russel S ^a   Wang, Jichuan ^a   Siegal, Harvey A ^a   Daniulaityte, Raminta ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

3,4 Methylenedioxymethamphetamine; Adverse consequences; Ecstasy; Ethnography; MDMA; Memory; Risk

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; ALCOHOL; ALPRAZOLAM; CANNABIS; COCAINE; DIAMORPHINE; FLUNITRAZEPAM; KETAMINE; LYSERGIDE; METHAMPHETAMINE; OXYCODONE; PSILOCYBINE; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BRAIN INJURY; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG FATALITY; DRUG SAFETY; FEMALE; HUMAN; INTERVIEW; LONG TERM EXPOSURE; MALE; MEMORY DISORDER; MORBIDITY; MULTIPLE DRUG ABUSE; PRIORITY JOURNAL; RISK; TOBACCO; UNITED STATES;

EID: 4143095858     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2004.03.004     Document Type: Article

References (75)

1. Agar M., Reisinger H. Going for the global: The case of ecstasy. Human Organization. 62:2003;1-11
2. Anonymous. (2001). Ecstasy: The key to preventing problem use lies in understanding the users' social networks. Addiction, 96, 1531-1532.
3. Baggott M.J. Preventing problems in ecstasy users: Reduce use to reduce harm. Journal of Psychoactive Drugs. 34:2002;145-162
4. Baggott, M., & Mendelson, J. (2001). Does MDMA cause brain damage? In J. Holland (Ed.), Ecstasy: The complete guide. Rochester, VT: Park Street Press.
5. Beck, J., & Rosenbaum, M. (1994). Pursuit of ecstasy: The MDMA experience. Albany, NY: State University of New York Press.
6. Bhattachary S., Powell J.H. Recreational use of 3,4- methylenedioxymethamphetamine (MDMA) or 'ecstasy': Evidence for cognitive impairment. Psychological Medicine. 31:2001;647-658
7. Biernacki P., Waldorf D. Snowball sampling: Problems and techniques of chain referral sampling. Social Methods & Research. 10:1981;141-163
8. Boeri, M. W., Sterk, C. E., & Elifson, K. W. (2003, March). "Rolling: The changing scenes and patterns of ecstasy use. Presented at the Society for Applied Anthropology Meetings, Portland, OR.
9. Bolla K.I., McCann U.D., Ricaurte G.A. Memory impairment in abstinent MDMA (ecstasy) users. Neurology. 51:1998;1532-1537
10. Borgatti, S. P. (1996a). ANTHROPAC 4. [Computer software]. Natick, MA: AnalyticTechnologies.
11. Borgatti, S. P. (1996b). ANTHROPAC 4 methods guide. Natick, MA: Analytic Technologies.
12. Boyd C.J., McCabe S.E., d'Arcy H. Ecstasy use among college undergraduates: Gender, race and sexual identity. Journal of Substance Abuse Treatment. 24:2003;209-215
13. Buchignani N. Using Folio Views for qualitative data analysis. Cultural Anthropology Methods. 8:1996;1-4
14. Carlson, R. G. (2001). Patterns and trends of MDMA use and sexual risk behavior in central Ohio. Invited paper. Presented in MDMA/Ecstasy research: Advances, challenges, future directions: A scientific conference. Bethesda, MD: National Institute on Drug Abuse, July 19-20.
15. Carlson R.G., Falck R.S., McCaughan J.A., Siegal H.A. MDMA/'ecstasy' use among young people in Ohio: Perceived risk and barriers to intervention. Journal of Psychoactive Drugs. 36:2004;181-189
16. Clark, L., Vojir, C., Hester, N. O., Foster, R., & Miller, K. L. (1998). MDS and QAP: How do children rate painful experiences? In V. C. de Munck & E. J. Sobo (Eds.), Using methods in the field: A practical introduction and casebook. Walnut Creek, CA: AltaMira Press.
17. Cole J., Bailey M., Sumnall H.R., Wagstaff G.F., King L.A. The content of ecstasy tablets: Implications for the study of their long-term effects. Addiction. 97:2002a;1531-1536
18. Cole J., Sumnall H. Altered states: The clinical effects of ecstasy. Pharmacology & Therapeutics. 98:2003;35-58
19. Cole J., Sumnall H., Grob C. Sorted: Ecstasy. The Psychologist. 15:2002b;464-467
20. Cole J., Sumnall H., Wagstaff G. What is a dose of ecstasy? Journal of Psychopharmacology. 16:2002c;185-186
21. Community Epidemiology Work Group. (2000). Epidemiologic trends in drug abuse: Advance report. Rockville, MD: National Institute on Drug Abuse.
22. Community Epidemiology Work Group. (2001). Epidemiologic trends in drug abuse (Vol. I). Rockville, MD: National Institute on Drug Abuse.
23. Community Epidemiology Work Group. (2002). Epidemiologic trends in drug abuse (Vol. I). Rockville, MD: National Institute on Drug Abuse.
24. Croft R.J., Mackay A.J., Mills A.T., Gruzeller J.G. The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology. 153:2001;373-379
25. Curran H.V. Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology. 42:2000;34-41
26. Doblin, R. (2000). Clarification of information presented on MTV's special on ecstasy, November 28, 2000. URL: http//65.18.176.18/media/mtvclarify. html.
27. Fabricius W.V., Nagoshi C.T., MacKinnon D.P. Concepts of drugs: Differences in conceptual structure across groups with different levels of drug experience. Addiction. 92:1997;847-858
28. Falck R., Russel S., Robert G., Carlson R., Wang J., Siegal H.A. Sources of information about MDMA (3,4-methylenedioxymethamphetamine): Perceived accuracy, importance, and implications for prevention among young adult users. Drug and Alcohol Dependence. 74:2004;45-54
29. Fielding, N. G., & Lee, R. M. (1998). Computer analysis and qualitative research. Thousand Oaks, CA: Sage Publications, Inc.
30. Glaser, B. G., & Strauss, A. L. (1967). The discovery of grounded theory: Strategies for qualitative research. Chicago, IL: Aldine Publication Company.
31. Grob C.S. Deconstructing ecstasy: The politics of MDMA research. Addiction Research. 8:2000;549-588
32. Hansen D., Maycock B., Lower T. Weddings, parties, anything..., a qualitative analysis of ecstasy use in Perth, Western Australia. International Journal of Drug Policy. 12:2001;181-199
33. Hayner G.N. MDMA misrepresentation: An unresolved problem for ecstasy users. Journal of Psychoactive Drugs. 34:2002;195-198
34. Heckathorn D.D. Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems. 44:1997;174-199
35. Heffernan T.M., Jarvis H., Rodgers J., Scholey A.B., Ling J. Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy. Human Psychopharmacology. 16:2001;607-612
36. Holland, J. (2001a). The history of MDMA. In J. Holland (Ed.), Ecstasy: The complete guide. Rochester, VT: Park Street Press.
37. Holland, J. (2001b). MDMA myths and rumors dispelled. In J. Holland (Ed.), Ecstasy: The complete guide. Rochester, VT: Park Street Press.
38. Johnston, L. D., O'Malley, P. M., & Bachman, J. G. (2002). Ecstasy use among American teens drops for the first time in recent years, and overall drug and alcohol use also decline in the year after 9/11. University of Michigan News and Information Services, Ann Arbor, MI [on-line], December 16. URL: www.monitoringthefuture.org; accessed March 5, 2003.
39. Kish S.J. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacology, Biochemistry and Behavior. 71:2002;845-855
40. Kuhn, T. S. (1970). The structure of scientific revolutions (2nd ed.). Chicago: The University of Chicago Press.
41. Landry M.J. MDMA: A review of epidemiologic data. Journal of Psychoactive Drugs. 34:2002;163-169
42. McCann U.D., Slate S.O., Ricaurte G.A. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Drug Safety. 15:1996;107-115
43. McCaughan, J. A., Carlson, R. G., Falck, R., & Siegal, H. A. (2003, March). From "Candy Kids" to "Chemi-Kids": Insights into the self-perceptions of youth in "The Rave Scene" and their implications for drug prevention. Presented at the Society for Applied Anthropology Meetings, Portland, OR.
44. McDowell D.M., Kleber H.D. MDMA: Its history and pharmacology. Psychiatric Annals. 24:1994;127-130
45. McElrath, K., & McEvoy, K. (1999). Ecstasy use in northern Ireland: A qualitative study. Belfast: Northern Ireland Statistics and Research Agency.
46. Morgan M.J. Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology. 141:1999;30-36
47. Morgan M.J. Ecstasy (MDMA): A review of its possible persistent psychological effects. Psychopharmacology. 152:2000;230-248
48. Obrocki J., Schmoldt A., Buchert R., Andersen B., Petersen K., Thomasius R. Specific neurotixicity of chronic use of ecstasy. Toxicology Letters. 127:2002;285-297
49. Parker H., Williams L., Aldridge J. The normalization of 'sensible' recreational drug use: Further evidence from the North West England longitudinal study. Sociology. 36:2002;941-964
50. Parrott A.C. Human psychopharmacology of ecstasy (MDMA): A review of 15 years of empirical research. Human Psychopharmacology. 16:2001;557-577
51. Parrott A.C., Buchanan T., Scholey A.B., Heffernan T., Ling J., Rodgers J. Ecstasy/MDMA attributed problems reported by novice moderate and heavy recreational users. Human Psychopharmacology. 17:2002;309-312
52. Parrott A.C., Sisk E., Turner J.D. Psychobiological problems in heavy "ecstasy" (MDMA) polydrug users. Drug and Alcohol Dependence. 60:2000;105-110
53. Ricaurte G.A., Finnegan K.T., Delanney L.E., Irwin I., Langston J.W. Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: Preliminary observations. Annals of the New York Academy of Science. 600:1990;699-710
54. Ricaurte G.A., Yuan J., McCann U.D. (+/-) 3,4- Methylenedioxymethamphetamine (MDMA), 'ecstasy'-induced serotonin neurotoxicity studies in animals. Neuropsychobiology. 42:2000;5-10
55. Rodgers J. Cognitive performance amongst recreational users of "ecstasy" Psychopharmacology. 151:2000;19-24
56. Rodgers J., Buchanan T., Scholey A.B., Heffernan T.M., Ling J., Parrott A. Differential effects of ecstasy and cannabis on self-reports of memory ability: A web-based study. Human Psychopharmacology. 16:2001;619-625
57. Rosenbaum M. Ecstasy: America's new "reefer madness" Journal of Psychoactive Drugs. 34:2002;137-142
58. Schifano F., Di Furia L., Minicuci N., Bricolo R. MDMA ("Ecstasy") consumption in the context of polydrug abuse: A report on 150 patients. Drug and Alcohol Dependence. 52:1998;85-90
59. Sherlock K., Conner M. Patterns of ecstasy use amongst club goers on the UK "dance scene" International Journal of Drug Policy. 10:1999;117-129
60. Shewan D., Dalgarno P., Reith G. Perceived risk and risk reduction among ecstasy users: The role of drug, set, and setting. International Journal of Drug Policy. 10:2000;431-453
61. Shiner M., Newburn T. Definitely, maybe not? the normalization of recreational drug use amongst young people. Sociology. 31:1997;511-529
62. Shulgin, A. T. (1981). Hallucinogens. In M. E. Wolff (Ed.), Burger's medicinal chemistry. New York: John Wiley and Sons.
63. Shulgin A.T. The background and chemistry of MDMA. Journal of Psychoactive Drugs. 18:1986;291-304
64. Simon N.G., Mattick R.P. The impact of regular ecstasy use on memory function. Addiction. 97:2002;1523-1529
65. Solowij N., Halle W., Lee N. Recreational MDMA use in Sydney: A profile of "ecstasy" users and their experiences with the drug. British Journal of Addiction. 87:1992;1161-1172
66. Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Techniques and procedures for developing grounded theory. Thousand Oaks, CA: Sage Publications, Inc.
67. Stuerenburg H.J., Petersen K., Baumer T., Rosenkranz M., Buhmann C., Thomasius R. Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users. Neuroendocrinology Letters. 23:2002;259-261
68. Thomasius R., Peterson K., Buchert R., Andersen B., Zapletalova P., Wartberg L., et al. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology. 167:2003;85-96
69. Topp L., Hando J., Dillon P., Roche A., Solowij N. Ecstasy use in Australia: Patterns of use and associated harm. Drug and Alcohol Dependence. 55:1999;105-115
70. Verkes R.J., Gijsman H.J., Pieters M., Schoemaker R.C., Visser S., Kuijpers M., et al. Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology. 153:2001;196-202
71. Vollenweider F.X., Liechti M.E., Gamma A., Greer G., Geyer M. Acute psychological and neuropsychological effects of MDMA in humans. Journal of Psychoactive Drugs. 34:2002;171-184
72. Weller, S. C., & Romney, A. K. (1988). Systematic data collection. Qualitative research methods (Vol. 10). Newbury Park, CA: Sage Publications.
73. Williamson S., Gossop M., Powis B., Griffiths P., Fountain J., Strang J. Adverse effects of stimulant drugs in a community sample of drug users. Drug and Alcohol Dependence. 44:1997;87-94
74. Wright State University, Dayton, OH, Center for Interventions, Treatment and Addictions Research. (2003, January). Surveillance of drug trends in the state of Ohio: June 2002-January 2003. Ohio Department of Alcohol and Drug Addiction Services (http://www.odadas.state.oh.us/). Columbus, OH.
75. Yacoubian G.S., Boyle C., Harding C.A., Loftus E.A. It's a rave new world: Estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees. Journal of Drug Education. 33:2003;187-196